JAK2V617F-positive polycythemia vera and Philadelphia chromosome-positive chronic myeloid leukemia: one patient with two distinct myeloproliferative disorders

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Leukemia 2008-07, Vol.22 (7), p.1454-1455
Hauptverfasser:	Cambier, N, Renneville, A, Cazaentre, T, Soenen, V, Cossement, C, Giraudier, S, Grardel, N, Laï, J-L, Rose, C, Preudhomme, C
Format:	Artikel
Sprache:	eng
Schlagworte:	Benzamides Biological and medical sciences Cancer Research Care and treatment Case studies Chronic myeloid leukemia Critical Care Medicine Diagnosis Diseases of red blood cells Fusion Proteins, bcr-abl - genetics Gene mutations Genetic aspects Health aspects Hematologic and hematopoietic diseases Hematology Humans Imatinib Mesylate Intensive Internal Medicine Janus Kinase 2 - genetics letter-to-the-editor Leukemia Leukemia, Myelogenous, Chronic, BCR-ABL Positive - complications Leukemia, Myelogenous, Chronic, BCR-ABL Positive - drug therapy Leukemia, Myelogenous, Chronic, BCR-ABL Positive - genetics Leukemias. Malignant lymphomas. Malignant reticulosis. Myelofibrosis Male Medical sciences Medicine Medicine & Public Health Middle Aged Mutation Myeloid leukemia Myeloproliferative diseases Myeloproliferative disorders Oncology Philadelphia chromosome Piperazines - therapeutic use Polycythemia Polycythemia vera Polycythemia Vera - complications Polycythemia Vera - genetics Polycythemias Protein kinases Pyrimidines - therapeutic use Risk factors
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!